GNPX
GNPX
NASDAQ · Biotechnology

Genprex Inc

$1.76
-0.01 (-0.57%)
As of Mar 31, 4:55 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.53M
Net Income
146.8K
Gross Margin
41.9%
Profit Margin
9.6%
Rev Growth
+19.5%
D/E Ratio
0.44
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 41.9% 41.9% 41.9%
Operating Margin 12.7% 12.8% 11.1%
Profit Margin 9.6% 10.1% 9.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.53M 1.54M 1.49M
Gross Profit 639.8K 646.8K 622.8K
Operating Income 193.5K 198.1K 165.1K
Net Income 146.8K 155.5K 142.3K
Gross Margin 41.9% 41.9% 41.9%
Operating Margin 12.7% 12.8% 11.1%
Profit Margin 9.6% 10.1% 9.6%
Rev Growth +19.5% +5.1% +5.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.58M 2.06M 2.01M
Total Equity 3.60M 3.62M 3.52M
D/E Ratio 0.44 0.57 0.57
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 279.3K 246.3K 227.4K
Free Cash Flow 124.0K 159.2K 163.1K